Epidemiology and Genetics of Clonal Hematopoiesis, a Premalignant Hematopoietic Stem Cell Condition PR Newswire Reykjavik, ICELAND, Nov. 6, 2023 Reykjavik, ICELAND, Nov. 6, 2023 /PRNewswire/ -- A...
D E Shaw & Co LP 06 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...
Geode Capital Management LLC 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
D E Shaw & Co LP 05 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...
Geode Capital Management LLC 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
D E Shaw & Co LP 04 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...
Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesda ...
Geode Capital Management LLC 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
D E Shaw & Co LP 03 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022...
Geode Capital Management LLC 02 October 2023 Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 14.5 | 5.47169811321 | 265 | 282.5 | 265 | 8198 | 271.99308368 | DE |
4 | -37.5 | -11.8296529968 | 317 | 328 | 265 | 7348 | 296.30491689 | DE |
12 | -46 | -14.1321044547 | 325.5 | 337.25 | 265 | 8365 | 316.37016485 | DE |
26 | -29.5 | -9.54692556634 | 309 | 339 | 265 | 7021 | 320.59621875 | DE |
52 | 7 | 2.56880733945 | 272.5 | 339 | 264 | 19217 | 302.66567501 | DE |
156 | 75.5 | 37.0098039216 | 204 | 339 | 204 | 22340 | 260.03217776 | DE |
260 | 47.125 | 20.2797202797 | 232.375 | 339 | 185.26 | 15307 | 255.37206404 | DE |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約